Hereditary Risk of ADHD

Introduction to Hereditary Factors

The American Academy of Pediatrics recognizes that ADHD has a strong genetic and familial component, with heritability rates ranging from 70-80%, making ADHD one of the most heritable neuropsychiatric disorders 1, 2

Parents with ADHD are more likely to have children with the disorder, requiring early diagnostic vigilance and proactive management 1, 2
The pattern of symptoms can vary between generations, with some children manifesting predominantly inattention symptoms while their parents may have had a combined presentation 5

The American Academy of Pediatrics recommends that pediatricians initiate ADHD evaluation in any child aged 4-18 years who presents with academic or behavioral problems and symptoms of inattention, hyperactivity, or impulsivity, especially with a positive family history 3, 1, 4
To establish a diagnosis, at least 6 symptoms of inattention and/or hyperactivity-impulsivity must be documented, present for at least 6 months, with information obtained from multiple sources using standardized scales based on DSM-5 5, 6

Parents who also have ADHD may need additional support to maintain consistent treatments, both pharmacological and behavioral, for their children 1, 2
The chronic care model and medical home may be particularly beneficial for families where parents also have ADHD 1

ADHD should be recognized as a chronic condition requiring longitudinal follow-up using principles of the medical home model 1, 4, 2
Discontinuation of treatment places individuals at higher risk of catastrophic outcomes, especially when parents also have ADHD 1, 8

For preschoolers (4-5 years), parent behavioral therapy should be the first line of treatment before considering medication 4, 2
For school-aged children (6-11 years), both FDA-approved medication and behavioral therapy are recommended, preferably both 4, 2
For adolescents (12-18 years), specific evaluation for substance use, anxiety, depression, and learning disabilities is necessary, as these comorbid conditions affect the therapeutic approach 1, 7